Posted On: 06/03/2015 5:42:50 PM
Post# of 63872
$GVDI on watch. Pr. $0.14
Enters Into Agreement, Receives Initial Purchase Order
To Commercialize Xytotest Breakthrough Cervical Cancer Device
Website
Shares Outstanding : 8.07M
Float: N/A
Headlines
Enters Into Agreement, Receives Initial Purchase Order
To Commercialize Xytotest Breakthrough Cervical Cancer Device
Website
Shares Outstanding : 8.07M
Float: N/A
Headlines
(0)
(0)
